# PAVAJ VASCULAR CORPORATION: Role of nanoparticle mediated drug delivery in preventing arteriovenous fistula stenosis

**Lab Budget Score:** 70/100

| Field | Value |
|---|---|
| Organization | PAVAJ VASCULAR CORPORATION |
| Location | ROCHESTER, MN |
| Project | Role of nanoparticle mediated drug delivery in preventing arteriovenous fistula stenosis |
| Project number | 1R44DK145259-01A1 |
| Mechanism | R44 |
| Institute | National Institute of Diabetes and Digestive and Kidney Diseases |
| Award | $1,094,070 |
| Awarded | 2026-09-02 |
| Project period | 2026-09-02 to 2028-04-30 |
| UEI | UAQRBA244HM7 |

## Why this score
- Award of $1M or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11405688). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.